Signal Messages in Pediatric Practice
https://doi.org/10.30895/2312-7821-2018-6-4-180-186
Abstract
Keywords
About the Authors
G. V. KutekhovaRussian Federation
Analyst of the 1st category of the Department for Expert Analysis of Medicinal Products’ Safety of the Division for Evaluation of Medicinal Products’ Safety
E. O. Zhuravleva
Russian Federation
Head of the Department for Expert Analysis of Medicinal Products’ Safety of the Division for Evaluation of Medicinal Products’ Safety
M. A. Darmostukova
Russian Federation
Senior Analyst of the Department for Evaluation of MIBPs Side Effects of the Division for Evaluation of Medicinal Products’ Safety
I. I. Snegireva
Russian Federation
Cand. Sci. (Med.), Head of the Department for Evaluation of MIBPs Side Effects of the Division for Evaluation of Medicinal Products’ Safety
N. Yu. Velts
Russian Federation
Cand. Sci. (Biol.), Assistant Professor, Senior Analyst of the Department of Expert Analysis Methodology of the Division for Evaluation of Medicinal Products’ Safety
R. N. Alyautdin
Russian Federation
MD, Dr. Sci. (Med.), Professor, Head of the Division for Evaluation of Medicinal Products’ Safety
E. V. Shubnikova
Russian Federation
Cand. Sci. (Med.), Senior Analyst of the Department of Expert Analysis Methodology of the Division for Evaluation of Medicinal Products’ Safety
References
1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008. Allergy. 2008;63(Suppl. 86):8–160. https://doi.org/10.1111/j.1398-9995.2007.01620.x
2. Zhuravleva EO, Velts NY, Kutekhova GV, Darmostukova MA, Alyautdin RN. Signal as a tool of the pharmacovigilance. Bezopasnost’ i risk farmakotherapii = Safety and Risk of Pharmacotherapy. 2018;6(2):61–7 (In Russ.)]. https://doi.org/10.30895/2312-7821-2018-6-2-61-67
3. Volosovets GG, Dushkina AE, Nastausheva TL. Infant obesity: risk factors, problems and treatment and prophylaxis prospects. Vestnik novykh meditsinskikh tekhnologij = Journal of New Medical Technologies. 2010;17(2):74–6 (In Russ.)
4. Astakhova AV, Lepakhin VK. Lekarstva. Neblagopriyatnye pobochnye reaktsii i kontrol’ bezopasnosti= Medicines. Adverse reactions and safety control. Moscow: Eksmo; 2008 (In Russ.)
5.
6. Kutekhova GV, Lepakhin VK, Romanov BK. Detection of violations in prescribing medicines (off-label prescriptions) in pediatric patients. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya = The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2012;(3):23–7 (In Russ.)
7. Viola E, Conforti А. Desloratadine, loratadine and weight increase in children. WHO Pharmaceuticals Newsletter 2017;4:15–9. Available from: http://apps.who.int/iris/bitstream/handle/10665/258800/WPN-2017-04-eng.pdf?sequence=1
8. Khaitov RM, Il’ina NI, eds. Allergologiya i immunologiya: natsional’noye rukovodstvo = Allergology and immunology: national guidance. Moscow: GEOTAR-Media; 2009 (In Russ.)
9. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008. Allergy. 2008;63(Suppl. 86):8–160. https://doi.org/10.1111/j.1398-9995.2007.01620.x
10. Volosovets GG, Dushkina AE, Nastausheva TL. Infant obesity: risk factors, problems and treatment and prophylaxis prospects. Vestnik novykh meditsinskikh tekhnologij = Journal of New Medical Technologies. 2010;17(2):74–6 (In Russ.)
11.
Review
For citations:
Kutekhova G.V., Zhuravleva E.O., Darmostukova M.A., Snegireva I.I., Velts N.Yu., Alyautdin R.N., Shubnikova E.V. Signal Messages in Pediatric Practice. Safety and Risk of Pharmacotherapy. 2018;6(4):180-186. (In Russ.) https://doi.org/10.30895/2312-7821-2018-6-4-180-186